25C-NB4OMe
|  | |
| Clinical data | |
|---|---|
| ATC code | 
 | 
| Identifiers | |
| IUPAC name 
 | |
| CAS Number | |
| PubChem CID | |
| ChemSpider | 
 | 
| UNII | |
| Chemical and physical data | |
| Formula | C18H22ClNO3 | 
| Molar mass | 335.83 g·mol−1 | 
| 3D model (JSmol) | |
| SMILES 
 | |
| InChI 
 | |
25C-NB4OMe (2C-C-NB4OMe, NB4OMe-2C-C) is a derivative of the phenethylamine hallucinogen 2C-C, which acts as a highly potent partial agonist for the human 5-HT2A receptor.[1][2]
Legality
United Kingdom
This substance is a Class A drug in the United Kingdom as a result of the N-benzylphenethylamine catch-all clause in the Misuse of Drugs Act 1971.[3]
References
- ↑ https://bitnest.netfirms.com/external.php?id=%2501%253B5%25168%250F%2518%250DG%257F%255B18%2521UYHRO%2500JAsca%2515%255C%5B%5D
- ↑ https://bitnest.netfirms.com/external.php?id=%2501%253B5%25168%250F%2518%250DG%257F%255B18%2521UYHZP%251CUTscc%250BWk%5B%5D
- ↑ "The Misuse of Drugs Act 1971 (Ketamine etc.) (Amendment) Order 2014". www.legislation.gov.uk.
| Serotonin receptor modulators | |||||||||||||||||||||||||||||||||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 5-HT1 | 
 | ||||||||||||||||||||||||||||||||||||||
| 5-HT2 | 
 | ||||||||||||||||||||||||||||||||||||||
| 5-HT3–7 | 
 | ||||||||||||||||||||||||||||||||||||||
| 
 | |||||||||||||||||||||||||||||||||||||||
| Phenethylamines | 
 
 
 
 
 | 
|---|---|
| Amphetamines | 
 | 
| Phentermines | 
 | 
| Cathinones | 
 | 
| Phenylisobutylamines | |
| Phenylalkylpyrrolidines | |
| Catecholamines (and close relatives) | 
 | 
| Miscellaneous | 
 | 
    This article is issued from Offline. The text is licensed under Creative Commons - Attribution - Sharealike. Additional terms may apply for the media files.
